- Home
- OPI vs COCP Comparison
OPI vs COCP Comparison
Compare OPI & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPI
- COCP
- Stock Information
- Founded
- OPI 2009
- COCP 2006
- Country
- OPI United States
- COCP United States
- Employees
- OPI N/A
- COCP 11
- Industry
- OPI Real Estate Investment Trusts
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- OPI Real Estate
- COCP Health Care
- Exchange
- OPI Nasdaq
- COCP Nasdaq
- Market Cap
- OPI 16.6M
- COCP 15.5M
- IPO Year
- OPI 2009
- COCP N/A
- Fundamental
- Price
- OPI $0.22
- COCP $1.57
- Analyst Decision
- OPI
- COCP Strong Buy
- Analyst Count
- OPI 0
- COCP 1
- Target Price
- OPI N/A
- COCP $6.00
- AVG Volume (30 Days)
- OPI 596.9K
- COCP 170.9K
- Earning Date
- OPI 07-30-2025
- COCP 08-14-2025
- Dividend Yield
- OPI 17.95%
- COCP N/A
- EPS Growth
- OPI N/A
- COCP N/A
- EPS
- OPI N/A
- COCP N/A
- Revenue
- OPI $466,972,000.00
- COCP N/A
- Revenue This Year
- OPI N/A
- COCP N/A
- Revenue Next Year
- OPI N/A
- COCP N/A
- P/E Ratio
- OPI N/A
- COCP N/A
- Revenue Growth
- OPI N/A
- COCP N/A
- 52 Week Low
- OPI $0.18
- COCP $1.12
- 52 Week High
- OPI $2.48
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- OPI 42.18
- COCP 45.42
- Support Level
- OPI $0.23
- COCP $1.45
- Resistance Level
- OPI $0.25
- COCP $1.71
- Average True Range (ATR)
- OPI 0.01
- COCP 0.10
- MACD
- OPI -0.00
- COCP -0.02
- Stochastic Oscillator
- OPI 12.00
- COCP 25.87
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).